Editorial: Cancer evolution.
Luca Ermini, Diego Mallo, Dimitrios Kleftogiannis, Ahmet Acar
Author Information
- Luca Ermini: NORLUX NeuroOncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health, Luxembourg, Luxembourg.
- Diego Mallo: Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, AZ, United States.
- Dimitrios Kleftogiannis: Department of Informatics, Computational Biology Unit and Centre for Cancer Biomarkers, University of Bergen, Bergen, Norway.
- Ahmet Acar: Department of Biological Sciences, Middle East Technical University, Universiteler Mah, Ankara, Turkiye.
No abstract text available.
- Annu Rev Cancer Biol. 2017 Mar;1:119-140
[PMID: 29399660]
- Nat Genet. 2016 Mar;48(3):238-244
[PMID: 26780609]
- Front Genet. 2020 Oct 15;11:570255
[PMID: 33193667]
- J Pers Med. 2020 Oct 19;10(4):
[PMID: 33086677]
- Cell. 2020 Apr 16;181(2):236-249
[PMID: 32302568]
- Front Sci. 2023;1:
[PMID: 37869257]
- Cold Spring Harb Perspect Med. 2017 Feb 1;7(2):
[PMID: 28148564]
- Methods. 2017 Dec 1;131:135-146
[PMID: 28669865]
- Annu Rev Genomics Hum Genet. 2019 Aug 31;20:309-329
[PMID: 31059289]
- Nat Commun. 2014 Nov 19;5:5499
[PMID: 25407411]
- Nat Rev Clin Oncol. 2020 Nov;17(11):675-686
[PMID: 32699310]
- Cancer Discov. 2022 Jan;12(1):31-46
[PMID: 35022204]
- EMBO J. 2021 Sep 15;40(18):e108389
[PMID: 34459009]
- Nature. 2012 Jan 18;481(7381):306-13
[PMID: 22258609]
- Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673):
[PMID: 26056363]
- R01 CA140657/NCI NIH HHS
- R21 CA257980/NCI NIH HHS
- U2C CA233254/NCI NIH HHS
- U54 CA217376/NCI NIH HHS
